Effects of CT-100, a DiNaMo Component on Cognitive Functioning and Mood Symptoms

Effects of CT-100, a DiNaMo Component on Cognitive Functioning and Mood Symptoms
Conditions:   Multiple Sclerosis;   Mild Cognitive Impairment;   Cancer
Interventions:   Other: CT-100 DiNaMo;   Other: Care-as-Usual
Sponsor:   Click Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments